AI technologies and their relationship with Intellectual Property (IP) rights have remained a prominent topic on the global agenda this year, as they were last year. With the increasing presence of generative AI models such as ChatGPT, BERT, LaMDA, and DALL-E2, which are capable of creating original content by processing data like text, images and sound, debates continue over whether the outputs generated by these models qualify as copyrighted works, who owns the rights to…
»
According to the Competition Authority's (“Authority”) activity report for 2023, it is seen that 68 of the 117 investigation files were concluded with settlements and 28 files were concluded with commitments. Although the activity report for 2024 has not yet been published by the Authority, announcements of final decisions on its website indicate that the majority of investigations in 2024 have also been concluded through settlement.
Investigation of competition law…
»
The pharmaceutical sector saw a 2.7% increase in production in 2023. However, between January and July of 2024, there was a 5.2% decrease compared to the same period in the previous year. By 2023, pharmaceutical imports increased by 8.8% reaching a value of 5.4 billion USD, while pharmaceutical exports grew by 15.8% to the size of 2.2 billion USD. In the first half of 2024, exports rose by 1.9%, while imports increased by 4.9% [1].
In 2023, the Turkish pharmaceutical market…
»
The export of products that are produced for and imported to the Turkish market after being introduced to the market may restrict patients’ access to treatment. Additionally, pharmaceutical products that are purchased at prices significantly lower than those in many other countries and then exported can influence the market prices in other countries. In this context, the Circular No. 2014/11 on the Availability of Pharmaceutical Products in the Market prepared by the Agency…
»
The Named Patient Programs (NPP) are import regimes that allow medicines not authorized in Türkiye or authorized but unavailable for various reasons to be imported from abroad upon request by a physician.
Following publication of the Regulation on the Importation of Medicines from Abroad ("NPP Regulation") published on 3 February 2023, the roles of stakeholders in the relevant process have been clarified. According to this NPP Regulation, institutions and organisations…
»
On 26 May 2023, significant changes were made to the Medical Device Promotion Regulation. These changes introduced several new procedures to the medical device sector. Rather than being regulated under separate legislation, these procedures were incorporated into the existing Medical Device Promotion Regulation.
According to the updated regulation, additional obligations have been introduced for authorised sales centres for medical devices. These include providing technical…
»
